| Drug Type Polysaccharide vaccine, Prophylactic vaccine | 
| Synonyms ACYW135群脑膜炎球菌多糖疫苗(北京天坛生物制品股份有限公司), Group ACYW135 meningococcal polysaccharide vaccine(Beijing Tiantan Biological Products) | 
| Target- | 
| Action stimulants | 
| Mechanism Immunostimulants | 
| Therapeutic Areas | 
| Active Indication | 
| Inactive Indication | 
| Originator Organization | 
| Active Organization | 
| Inactive Organization | 
| License Organization- | 
| Drug Highest PhaseApproved | 
| First Approval Date China (30 Sep 2022),  | 
| Regulation- | 
| Indication | Country/Location | Organization | Date | 
|---|---|---|---|
| Meningitis | China  | 30 Sep 2022 | 
| Indication | Highest Phase | Country/Location | Organization | Date | 
|---|---|---|---|---|
| Meningitis, Pneumococcal | Preclinical | China  | 20 Jul 2016 | |
| Meningococcal Infections | Preclinical | China  | 20 Apr 2016 | 





